Stock VIRI VIRIOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.4695 USD +3.01% Intraday chart for Virios Therapeutics, Inc. +7.81% -18.35%
Feb. 29 Virios Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Jan. 22 Virios Therapeutics Announces Plans to Advance Development of Imc-2 as Treatment for Symptoms Associated with Long-Covid CI

Evolution of the average Target Price on Virios Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d9.wb_GFRMCDAAGQk_Orey_ozbWivFoCkVBLt3UbPbaog4.jOilfXdRYGxNJCiH8rn3yWyP2LxdaQpwZI25D6S5-lG28I5cZ2dOemAXCg~31218b29e6498b7e9e701149f703630c

Analyst Recommendations on Virios Therapeutics, Inc.

US Futures Lower as Investors Gird for Another Fed Rate Increase MT
HC Wainwright Downgrades Virios Therapeutics to Neutral From Buy MT
HC Wainwright Starts Virios Therapeutics at Buy With $12 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.4695 USD
Average target price
2.2 USD
Spread / Average Target
+368.58%
High Price Target
4 USD
Spread / Highest target
+751.97%
Low Price Target
0.4 USD
Spread / Lowest Target
-14.80%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Virios Therapeutics, Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VIRI Stock
  4. Consensus Virios Therapeutics, Inc.